- Home
- Publications
- Publication Search
- Publication Details
Title
Engineered cellular immunotherapies in cancer and beyond
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 28, Issue 4, Pages 678-689
Publisher
Springer Science and Business Media LLC
Online
2022-04-19
DOI
10.1038/s41591-022-01765-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Decade-long leukaemia remissions with persistence of CD4+ CAR T cells
- (2022) J. Joseph Melenhorst et al. NATURE
- CAR T cells produced in vivo to treat cardiac injury
- (2022) Joel G. Rurik et al. SCIENCE
- Current Concepts and Advances in Graft-Versus-Host Disease Immunology
- (2021) Geoffrey R. Hill et al. Annual Review of Immunology
- Immune Biology of Acute Myeloid Leukemia: Implications for Immunotherapy
- (2021) Sophia Khaldoyanidi et al. JOURNAL OF CLINICAL ONCOLOGY
- A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy
- (2021) Shoichi Iriguchi et al. Nature Communications
- Will allogeneic CAR T cells for CD19+ malignancies take autologous CAR T cells ‘off the shelf’?
- (2021) Amanda M. DiNofia et al. Nature Reviews Clinical Oncology
- Genetic engineering of T cells for immunotherapy
- (2021) Gavin I. Ellis et al. NATURE REVIEWS GENETICS
- Chimeric antigen receptor T-cell therapy for HIV cure
- (2021) Oscar Alfageme-Abello et al. Current Opinion in HIV and AIDS
- Investigation of product derived lymphoma following infusion of piggyBac modified CD19 chimeric antigen receptor T-cells
- (2021) Kenneth Paul Micklethwaite et al. BLOOD
- The microbiome and human cancer
- (2021) Gregory D. Sepich-Poore et al. SCIENCE
- Synthetic Lethality in Cancer Therapeutics: The Next Generation
- (2021) Jeremy Setton et al. Cancer Discovery
- Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy
- (2021) Ramazan Rezaei et al. CANCER GENE THERAPY
- Immune Cells and Immunotherapy for Cardiac Injury and Repair
- (2021) Joel G. Rurik et al. CIRCULATION RESEARCH
- Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma
- (2021) Samantha J. Seitter et al. CLINICAL CANCER RESEARCH
- CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
- (2021) Dimitrios Mougiakakos et al. NEW ENGLAND JOURNAL OF MEDICINE
- AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia
- (2021) Waqas Nawaz et al. Blood Cancer Journal
- A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
- (2021) Prasad S Adusumilli et al. Cancer Discovery
- Real-World Experiences of CAR T-Cell Therapy for Large B-Cell Lymphoma: How Similar Are They to the Prospective Studies?
- (2021) Kevin Tang et al. Journal of Immunotherapy and Precision Oncology
- Charting the tumor antigen maps drawn by single-cell genomics
- (2021) Caleb A. Lareau et al. CANCER CELL
- An NK-like CAR T cell transition in CAR T cell dysfunction
- (2021) Charly R. Good et al. CELL
- Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs
- (2021) Mark Yarmarkovich et al. NATURE
- Off-the-shelf, gene-edited CAR-T cells forge ahead, despite safety scare
- (2021) Cormac Sheridan NATURE BIOTECHNOLOGY
- Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy
- (2021) Oliver Van Oekelen et al. NATURE MEDICINE
- Immune and Genome Engineering as the Future of Transplantable Tissue
- (2021) Jennifer Elisseeff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Induced Pluripotent Stem Cell-Derived Macrophages Ameliorate Liver Fibrosis
- (2021) Somayeh Pouyanfard et al. STEM CELLS
- Current development in adenoviral vectors for cancer immunotherapy
- (2021) Greyson Willis Grossman Biegert et al. Molecular Therapy-Oncolytics
- ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges
- (2020) S. Depil et al. NATURE REVIEWS DRUG DISCOVERY
- Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
- (2020) Jonathan U. Peled et al. NEW ENGLAND JOURNAL OF MEDICINE
- CRISPR-engineered T cells in patients with refractory cancer
- (2020) Edward A. Stadtmauer et al. SCIENCE
- An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors
- (2020) Katharina Reinhard et al. SCIENCE
- Impaired death receptor signaling in leukemia causes antigen-independent resistance by inducing CAR T cell dysfunction
- (2020) Nathan Singh et al. Cancer Discovery
- In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes
- (2020) Shiwani Agarwal et al. MOLECULAR THERAPY
- Human chimeric antigen receptor macrophages for cancer immunotherapy
- (2020) Michael Klichinsky et al. NATURE BIOTECHNOLOGY
- Engineering CAR-T Cells for Next-Generation Cancer Therapy
- (2020) Mihe Hong et al. CANCER CELL
- Dendritic cell therapy in cancer treatment; the state-of-the-art
- (2020) Mahsa Sadeghzadeh et al. LIFE SCIENCES
- Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia
- (2020) Meir Rozenbaum et al. Frontiers in Immunology
- Viral Delivery of CAR Targets to Solid Tumors Enables Effective Cell Therapy
- (2020) Amin Aalipour et al. Molecular Therapy-Oncolytics
- Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies
- (2020) Kevin R. Parker et al. CELL
- Designed protein logic to target cells with precise combinations of surface antigens
- (2020) Marc J. Lajoie et al. SCIENCE
- Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors
- (2020) Anthony K. Park et al. Science Translational Medicine
- Discriminatory Power of Combinatorial Antigen Recognition in Cancer T Cell Therapies
- (2020) Ruth Dannenfelser et al. Cell Systems
- Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
- (2020) Sreya Bagchi et al. Annual Review of Pathology-Mechanisms of Disease
- Taming the beast: CRS and ICANS after CAR T-cell therapy for ALL
- (2020) Vipul S Sheth et al. BONE MARROW TRANSPLANTATION
- Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
- (2020) Reuben Benjamin et al. LANCET
- Gene therapy using haematopoietic stem and progenitor cells
- (2020) Giuliana Ferrari et al. NATURE REVIEWS GENETICS
- CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
- (2020) Haydar Frangoul et al. NEW ENGLAND JOURNAL OF MEDICINE
- Precise T cell recognition programs designed by transcriptionally linking multiple receptors
- (2020) Jasper Z. Williams et al. SCIENCE
- The role of the intestinal microbiota in allogeneic HCT: clinical associations and preclinical mechanisms
- (2020) Chi L Nguyen et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation
- (2019) Agnieszka Czechowicz et al. Nature Communications
- A defined commensal consortium elicits CD8 T cells and anti-cancer immunity
- (2019) Takeshi Tanoue et al. NATURE
- New Human Chromosomal Sites with “Safe Harbor” Potential for Targeted Transgene Insertion
- (2019) Stefan Pellenz et al. HUMAN GENE THERAPY
- Chimeric antigen receptor–T cell therapy manufacturing: modelling the effect of offshore production on aggregate cost of goods
- (2019) Richard P. Harrison et al. CYTOTHERAPY
- Manufacturing chimeric antigen receptor T cells: issues and challenges
- (2019) Claire Roddie et al. CYTOTHERAPY
- Intestinal Microbiome Analyses Identify Biomarkers for Patient Response to CAR T Cell Therapy
- (2019) Melody Smith et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity
- (2019) Bryan D. Choi et al. NATURE BIOTECHNOLOGY
- T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant
- (2019) Aude G. Chapuis et al. NATURE MEDICINE
- Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response
- (2019) Patrick A. Baeuerle et al. Nature Communications
- Novel Targeting to XCR1+ Dendritic Cells Using Allogeneic T Cells for Polytopical Antibody Responses in the Lymph Nodes
- (2019) Yusuke Kitazawa et al. Frontiers in Immunology
- Targeting cardiac fibrosis with engineered T cells
- (2019) Haig Aghajanian et al. NATURE
- Clinical lessons learned from the first leg of the CAR T cell journey
- (2019) Robbie G. Majzner et al. NATURE MEDICINE
- Autoimmunity as a target for chimeric immune receptor therapy: A new vision to therapeutic potential
- (2019) Mohammad-Hossein Haddadi et al. BLOOD REVIEWS
- Why and where an HIV cure is needed and how it might be achieved
- (2019) Thumbi Ndung’u et al. NATURE
- T Cell Dysfunction in Cancer
- (2018) Daniela S. Thommen et al. CANCER CELL
- Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia
- (2018) Miriam Y. Kim et al. CELL
- Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
- (2018) Ye Li et al. Cell Stem Cell
- Niches for Hematopoietic Stem Cells and Their Progeny
- (2018) Qiaozhi Wei et al. IMMUNITY
- Visualizing the Rapid and Dynamic Elimination of Allogeneic T Cells in Secondary Lymphoid Organs
- (2018) Yasuhiro Kanda et al. JOURNAL OF IMMUNOLOGY
- Chimeric Antigen Receptor Therapy
- (2018) Carl H. June et al. NEW ENGLAND JOURNAL OF MEDICINE
- Contemporary Strategies and Barriers to Transplantation Tolerance
- (2018) Brian Ezekian et al. TRANSPLANTATION
- Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates
- (2018) Agne Taraseviciute et al. Cancer Discovery
- Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus–Driven Production of a Bispecific T-cell Engager
- (2018) Anna Wing et al. Cancer Immunology Research
- Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors
- (2018) Vincent Yi Sheng Oei et al. Cancer Immunology Research
- Biomanufacturing for clinically advanced cell therapies
- (2018) Ayesha Aijaz et al. Nature Biomedical Engineering
- In vivo generation of human CD19‐CAR T cells results in B‐cell depletion and signs of cytokine release syndrome
- (2018) Anett Pfeiffer et al. EMBO Molecular Medicine
- Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
- (2018) Sarwish Rafiq et al. NATURE BIOTECHNOLOGY
- Checkpoint blockade reverses anergy in IL13Rα2 humanized scFv based CAR T cells to treat murine and canine gliomas.
- (2018) Yibo Yin et al. Molecular Therapy-Oncolytics
- ASBMT Consensus Grading for Cytokine Release Syndrome and Neurological Toxicity Associated with Immune Effector Cells
- (2018) Daniel W Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontier
- (2018) Jonathan H. Esensten et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- CAR-T Cells and Oncolytic Viruses: Joining Forces to Overcome the Solid Tumor Challenge
- (2018) Sonia Guedan et al. Frontiers in Immunology
- Shared cancer neoantigens: Making private matters public
- (2017) Christopher A. Klebanoff et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer
- (2017) Amanda Rosewell Shaw et al. MOLECULAR THERAPY
- Is autoimmunity the Achilles' heel of cancer immunotherapy?
- (2017) Carl H June et al. NATURE MEDICINE
- The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells
- (2017) Michal P. Kuczma et al. Oncotarget
- CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
- (2017) Levi J. Rupp et al. Scientific Reports
- CAR T Cells Releasing IL-18 Convert to T-Bet high FoxO1 low Effectors that Exhibit Augmented Activity against Advanced Solid Tumors
- (2017) Markus Chmielewski et al. Cell Reports
- Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants
- (2017) Giedre Krenciute et al. Cancer Immunology Research
- Global Manufacturing of CAR T Cell Therapy
- (2017) Bruce L. Levine et al. Molecular Therapy-Methods & Clinical Development
- Prospects for combined use of oncolytic viruses and CAR T-cells
- (2017) Adam Ajina et al. Journal for ImmunoTherapy of Cancer
- Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia
- (2016) Joseph A. Fraietta et al. BLOOD
- Immune checkpoint blockade: Releasing the brake towards hematological malignancies
- (2016) Yi Xia et al. BLOOD REVIEWS
- Oncolytic virus therapy: A new era of cancer treatment at dawn
- (2016) Hiroshi Fukuhara et al. CANCER SCIENCE
- Microbiome and Anticancer Immunosurveillance
- (2016) Laurence Zitvogel et al. CELL
- Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
- (2016) Jiangtao Ren et al. CLINICAL CANCER RESEARCH
- Heterogeneity of the bone marrow niche
- (2016) Vionnie W.C. Yu et al. CURRENT OPINION IN HEMATOLOGY
- Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
- (2016) Avery D. Posey et al. IMMUNITY
- Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia
- (2016) Paulina J. Paszkiewicz et al. JOURNAL OF CLINICAL INVESTIGATION
- A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo
- (2016) S Hipp et al. LEUKEMIA
- Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma
- (2016) Mikko Siurala et al. MOLECULAR THERAPY
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
- (2016) C. T. Ellebrecht et al. SCIENCE
- Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune Targets
- (2016) Marieke Griffioen et al. Frontiers in Immunology
- Allorecognition by T Lymphocytes and Allograft Rejection
- (2016) Jose Marino et al. Frontiers in Immunology
- Phase I study with ONCOS-102 for the treatment of solid tumors – an evaluation of clinical response and exploratory analyses of immune markers
- (2016) Tuuli Ranki et al. Journal for ImmunoTherapy of Cancer
- Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation
- (2015) Stefan O. Ciurea et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Bone Marrow Cell Rejection, MHC, NK Cells, and Missing Self Recognition: Ain’t That Peculiar (with Apologies to Marvin Gaye)
- (2015) David H. Raulet JOURNAL OF IMMUNOLOGY
- Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes
- (2015) Ignazio Caruana et al. NATURE MEDICINE
- Overcoming T cell exhaustion in infection and cancer
- (2015) Kristen E. Pauken et al. TRENDS IN IMMUNOLOGY
- CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells
- (2015) Alexander J. Davenport et al. Cancer Immunology Research
- Long-Term Safety Issues of iPSC-Based Cell Therapy in a Spinal Cord Injury Model: Oncogenic Transformation with Epithelial-Mesenchymal Transition
- (2015) Satoshi Nori et al. Stem Cell Reports
- IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumorsin vivo
- (2015) Mythili Koneru et al. OncoImmunology
- The Role of Mechanical Forces in Tumor Growth and Therapy
- (2014) Rakesh K. Jain et al. Annual Review of Biomedical Engineering
- Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
- (2014) G. L. Beatty et al. CLINICAL CANCER RESEARCH
- A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer
- (2013) Kenneth H. Kim et al. GYNECOLOGIC ONCOLOGY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Perspective: Assembly line immunotherapy
- (2013) Bruce L. Levine et al. NATURE
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
- (2013) S. Viaud et al. SCIENCE
- Cell-Based Therapeutics: The Next Pillar of Medicine
- (2013) M. A. Fischbach et al. Science Translational Medicine
- Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells
- (2013) B. J. Cameron et al. Science Translational Medicine
- World Distribution, Population Genetics, and Health Burden of the Hemoglobinopathies
- (2013) T. N. Williams et al. Cold Spring Harbor Perspectives in Medicine
- The Microbiome in Infectious Disease and Inflammation
- (2012) Kenya Honda et al. Annual Review of Immunology
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Innate NK Cells and Macrophages Recognize and Reject Allogeneic Nonself In Vivo via Different Mechanisms
- (2012) W. Liu et al. JOURNAL OF IMMUNOLOGY
- Agonistic Antibody to CD40 Boosts the Antitumor Activity of Adoptively Transferred T Cells In Vivo
- (2012) Chengwen Liu et al. JOURNAL OF IMMUNOTHERAPY
- Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
- (2012) J. Scholler et al. Science Translational Medicine
- The allogeneic graft-versus-cancer effect
- (2009) Olle Ringdén et al. BRITISH JOURNAL OF HAEMATOLOGY
- Resistance of mature T cells to oncogene transformation
- (2008) S. Newrzela et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started